A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,288,535 shares of IPA stock, worth $1.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,288,535
Previous 1,281,305 0.56%
Holding current value
$1.3 Million
Previous $2.19 Million 10.59%
% of portfolio
0.09%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.4 - $2.41 $10,122 - $17,424
7,230 Added 0.56%
1,288,535 $1.96 Million
Q4 2023

Jan 29, 2024

BUY
$1.11 - $2.3 $280,887 - $582,019
253,052 Added 24.61%
1,281,305 $2.19 Million
Q3 2023

Nov 02, 2023

SELL
$1.76 - $3.04 $55,971 - $96,678
-31,802 Reduced 3.0%
1,028,253 $1.88 Million
Q2 2023

Jul 27, 2023

BUY
$2.42 - $4.04 $4,888 - $8,160
2,020 Added 0.19%
1,060,055 $3.14 Million
Q1 2023

May 09, 2023

BUY
$2.77 - $5.49 $243,449 - $482,505
87,888 Added 9.06%
1,058,035 $2.93 Million
Q4 2022

Jan 31, 2023

BUY
$4.5 - $5.72 $13,756 - $17,486
3,057 Added 0.32%
970,147 $5.05 Million
Q3 2022

Oct 21, 2022

BUY
$3.77 - $6.39 $104,108 - $176,459
27,615 Added 2.94%
967,090 $3.86 Million
Q2 2022

Aug 11, 2022

BUY
$3.8 - $6.08 $27,645 - $44,232
7,275 Added 0.78%
939,475 $3.57 Million
Q1 2022

May 09, 2022

BUY
$3.64 - $6.49 $407,468 - $726,503
111,942 Added 13.65%
932,200 $4.79 Million
Q4 2021

Feb 11, 2022

BUY
$5.06 - $6.69 $1.01 Million - $1.33 Million
198,811 Added 31.99%
820,258 $4.4 Million
Q3 2021

Oct 27, 2021

BUY
$5.14 - $13.22 $106,074 - $272,821
20,637 Added 3.43%
621,447 $3.87 Million
Q2 2021

Aug 03, 2021

BUY
$6.02 - $12.91 $503,362 - $1.08 Million
83,615 Added 16.17%
600,810 $3.62 Million
Q1 2021

Apr 21, 2021

BUY
$8.84 - $17.0 $1.07 Million - $2.05 Million
120,770 Added 30.46%
517,195 $5.08 Million
Q4 2020

Jan 27, 2021

BUY
$6.15 - $18.7 $2.44 Million - $7.41 Million
396,425 New
396,425 $5.93 Million

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $25.1M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.